Anti-Cyclic Citrullinated Peptide (Anti-CCP) High
This biomarker measures the level of anti-cyclic citrullinated peptide antibodies in the blood, which are often elevated in rheumatoid arthritis.
High levels of Anti-CCP indicate a strong likelihood of rheumatoid arthritis.
Key facts at a glance
- Units
- U/mL
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- Roche Anti-CCP High, Abbott Anti-CCP High
Anti-Cyclic Citrullinated Peptide (Anti-CCP) antibodies are autoantibodies that target citrullinated proteins in the body. Elevated levels of these antibodies are strongly associated with rheumatoid arthritis (RA), making Anti-CCP a valuable diagnostic tool.
The presence of Anti-CCP antibodies can often be detected before the onset of clinical symptoms, allowing for early diagnosis and intervention. This can be crucial in managing the disease and preventing joint damage.
A high Anti-CCP result, particularly above 20 U/mL, is highly specific for RA and can help differentiate it from other inflammatory conditions. This specificity makes it a preferred test in the diagnostic workup for suspected RA.
Frequently asked questions
What does a high Anti-CCP level mean?
Can Anti-CCP levels change over time?
Sources
- 1
- 2Mayo ClinicSource
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy